<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Microsatellite stable (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MSS</z:e>), CpG island methylator phenotype (CIMP)-negative <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e>, the most prevalent molecular subtype of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, are associated with extensive copy number alteration (CNA) events and <z:mp ids='MP_0004024'>aneuploidy</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>We report on the identification of characteristic recurrent CNA (with frequency &gt;25%) events and associated gene expression profiles for a total of 40 paired <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> colon tissues using genome-wide microarrays </plain></SENT>
<SENT sid="2" pm="."><plain>We observed recurrent CNAs, namely gains at 1q, 7p, 7q, 8p12-11, 8q, 12p13, 13q, 20p, 20q, Xp, and Xq and losses at 1p36, 1p31, 1p21, 4p15-12, 4q12-35, 5q21-22, 6q26, 8p, 14q, 15q11-12, 17p, 18p, 18q, 21q21-22, and 22q </plain></SENT>
<SENT sid="3" pm="."><plain>Within these genomic regions we identified 356 genes with significant differential expression (P &lt; 0.0001 and ±1.5-fold change) in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> compared to adjacent <z:mpath ids='MPATH_458'>normal</z:mpath> tissue </plain></SENT>
<SENT sid="4" pm="."><plain>Gene ontology and pathway analyses indicated that many of these genes were involved in functional mechanisms that regulate cell cycle, cell <z:hpo ids='HP_0011420'>death</z:hpo>, and metabolism </plain></SENT>
<SENT sid="5" pm="."><plain>An amplicon present in &gt;70% of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples at 20q11-20q13 contained several <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-related genes (AHCY, POFUT1, RPN2, TH1L, and PRPF6) that were upregulated and demonstrated a significant linear correlation (P &lt; 0.05) for gene dosage and gene expression </plain></SENT>
<SENT sid="6" pm="."><plain>Copy number loss at 8p, a CNA associated with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and poor prognosis, was observed in &gt;50% of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> samples and demonstrated a significant linear correlation for gene dosage and gene expression for two potential <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor genes, MTUS1 (8p22) and PPP2CB (8p12) </plain></SENT>
<SENT sid="7" pm="."><plain>The results from our integration analysis illustrate the complex relationship between genomic alterations and gene expression in <z:hpo ids='HP_0003003'>colon cancer</z:hpo>. © 2013 Wiley Periodicals, Inc </plain></SENT>
</text></document>